Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1666 AL 1680

Amyloid-β PET in Alzheimer's disease: A systematic review and Bayesian meta-analysis

Ruan D, Sun L.

Brain Behav. 2023 Jan;13(1):e2850. doi: 10.1002/brb3.2850. Epub 2022 Dec 27.

Commentary on Comparison of Machine Learning-based Approaches to Predict the Conversion to Alzheimer's Disease from Mild Cognitive Impairment

Rossini PM, Miraglia F, Vecchio F.

Neuroscience. 2023 Mar 15;514:141-142. doi: 10.1016/j.neuroscience.2022.12.018. Epub 2022 Dec 30.

Omega-3 fatty acids and cognitive function

Welty FK.

Curr Opin Lipidol. 2023 Feb 1;34(1):12-21. doi: 10.1097/MOL.0000000000000862. Epub 2022 Nov 25.

Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer's disease

Kumar A, Fontana IC, Nordberg A.

J Neurochem. 2023 Feb;164(3):309-324. doi: 10.1111/jnc.15565. Epub 2022 Jan 7.

Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease

Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, Ramdas K, Wishard T, McInerney KF, Vellas B, Sierra F, Jiang Z, Mcclain-Moss L, Perez C, Fuquay A, Rodriguez S, Hare JM, Oliva AA Jr, Baumel B.

Alzheimers Dement. 2023 Jan;19(1):261-273. doi: 10.1002/alz.12651. Epub 2022 Mar 31.

Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

Jessen F, Wolfsgruber S, Kleineindam L, Spottke A, Altenstein S, Bartels C, Berger M, Brosseron F, Daamen M, Dichgans M, Dobisch L, Ewers M, Fenski F, Fliessbach K, Freiesleben SD, Glanz W, Görß D, Gürsel S, Janowitz D, Kilimann I, Kobeleva X, Lohse A, Maier F, Metzger C, Munk M, Preis L, Sanzenbacher C, Spruth E, Rauchmann B, Vukovich R, Yakupov R, Weyrauch AS, Ziegler G, Schmid M, Laske C, Perneczky R, Schneider A, Wiltfang J, Teipel S, Bürger K, Priller J, Peters O, Ramirez A, Boecker H, Heneka MT, Wagner M, Düzel E.

Alzheimers Dement. 2023 Feb;19(2):487-497. doi: 10.1002/alz.12674. Epub 2022 Apr 22.

Recent Advances in Frontotemporal Dementia

Tartaglia MC, Mackenzie IRA.

Can J Neurol Sci. 2023 Jul;50(4):485-494. doi: 10.1017/cjn.2022.69. Epub 2022 May 30.

Effect of nutritional supports on malnutrition, cognition, function and biomarkers of Alzheimer's disease: a systematic review

Kocatürk RR, Temizyürek A, Özcan ÖÖ, Ergüzel TT, Karahan M, Konuk M, Tarhan N.

Int J Neurosci. 2023 Dec;133(12):1355-1373. doi: 10.1080/00207454.2022.2079506. Epub 2022 Jul 3.

Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity

Zicha S, Bateman RJ, Shaw LM, Zetterberg H, Bannon AW, Horton WA, Baratta M, Kolb HC, Dobler I, Mordashova Y, Saad ZS, Raunig DL, Spanakis EM, Li Y, Schindler SE, Ferber K, Rubel CE, Martone RL, Weber CJ, Edelmayer RM, Meyers EA, Bollinger JG, Rosenbaugh EG, Potter WZ; Alzheimer's Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ as a Predictor of Amyloid Positivity in Alzheimer's Disease Project Team.

Alzheimers Dement. 2023 Mar;19(3):956-966. doi: 10.1002/alz.12697. Epub 2022 Jul 12.

CD33 isoforms in microglia and Alzheimer's disease: Friend and foe

Eskandari-Sedighi G, Jung J, Macauley MS.

Mol Aspects Med. 2023 Apr;90:101111. doi: 10.1016/j.mam.2022.101111. Epub 2022 Aug 5.

Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis

Hazan J, Wing M, Liu KY, Reeves S, Howard R.

J Neurol Neurosurg Psychiatry. 2023 Feb;94(2):113-120. doi: 10.1136/jnnp-2022-329530. Epub 2022 Sep 12.

Recent progress in the graphene-based biosensing approaches for the detection of Alzheimer's biomarkers

Rouhi N, Akhgari A, Orouji N, Nezami A, Rahimzadegan M, Kamali H.

J Pharm Biomed Anal. 2023 Jan 5;222:115084. doi: 10.1016/j.jpba.2022.115084. Epub 2022 Sep 28.

Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4

Weiner MW, Veitch DP, Miller MJ, Aisen PS, Albala B, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2023 Jan;19(1):307-317. doi: 10.1002/alz.12797. Epub 2022 Oct 9.

Successful aging after elective surgery II: Study design and methods

Hshieh TT, Schmitt EM, Fong TG, Arnold S, Cavallari M, Dickerson BC, Dillon ST, Jones RN, Libermann TA, Marcantonio ER, Pascual-Leone A, Shafi MM, Touroutoglou A, Travison TG, Gou RY, Tommet D, Abdeen A, Earp B, Kunze L, Lange J, Vlassakov K, Inouye SK; SAGES II Study Team.

J Am Geriatr Soc. 2023 Jan;71(1):46-61. doi: 10.1111/jgs.18065. Epub 2022 Oct 10.

Retinal Neurodegeneration Measured With Optical Coherence Tomography and Neuroimaging in Alzheimer Disease: A Systematic Review

Carazo-Barrios L, Cabrera-Maestre A, Alba-Linero C, Gutiérrez-Bedmar M, Garzón-Maldonado FJ, Serrano V, de la Cruz-Cosme C, García-Casares N.

J Neuroophthalmol. 2023 Mar 1;43(1):116-125. doi: 10.1097/WNO.0000000000001673. Epub 2022 Oct 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias